6-84125191-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014895.4(CEP162):c.4091G>A(p.Arg1364His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000191 in 1,613,642 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1364C) has been classified as Uncertain significance.
Frequency
Consequence
NM_014895.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000323 AC: 81AN: 250806Hom.: 1 AF XY: 0.000406 AC XY: 55AN XY: 135548
GnomAD4 exome AF: 0.000203 AC: 297AN: 1461364Hom.: 6 Cov.: 31 AF XY: 0.000298 AC XY: 217AN XY: 726974
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4091G>A (p.R1364H) alteration is located in exon 27 (coding exon 26) of the CEP162 gene. This alteration results from a G to A substitution at nucleotide position 4091, causing the arginine (R) at amino acid position 1364 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at